MENU

Public Relations

Coverage

FY2025

You can scroll horizontally.

No. Date Media Broadcasting channel
Newspaper, journal
Headline, title Page
114 7/31/2025 Newspaper/Web Nikkan Kogyo Shimbun National Cancer Center Japan clarifies mechanism by which senescent cells do not die from iron. p.30
113 7/30/2025 Newspaper Nikkan Yakugyo Elevidys Deaths Affect Strategies of Emerging Companies Merck Loan of Germany, "Investors are also concerned about risks.  
112 7/17/2025 Web/Magazine iNewsletter 2025 Summer Issue iCONM NOW: Expectations for the treatment of intractable cancers and incurable diseases using siRNA p.4
111 7/16/2025 Web Science Japan (Chinese) University of Tokyo and iCONM Develop Nanomachine to Deliver Nucleic Acid Drugs to Sentinel Lymph Nodes to Prevent Cancer Metastasis  
110 7/16/2025 Web QLife Pro New technology developed to deliver antibody drugs to intracellular targets in cancer cells, utilizing wine astringent ingredients  
109 7/15/2025 Web Biz Zine News Dai-ichi Life Holdings and the University of Tokyo Launch Joint Research to Construct New Indicator of "Happiness Life Expectancy  
108 7/15/2025 Web Women's Lab Dai-ichi Life Insurance and the University of Tokyo to Construct a New Social Indicator, “Life Span of Happiness,” Aiming to Visualize Well-Being  
107 7/15/2025 Web Eichie [Cancer Control] Polyphenols deliver antibodies inside cancer cells, Institute of Science Tokyo  
106 7/11/2025 Web Phys & Org Polyphenol-conjugated nanocarrier system enhances antibody therapies for breast cancer  
105 7/11/2025 Web StatNano Polyphenol-conjugated nanocarrier system enhances antibody therapies for breast cancer  
104 7/11/2025 Web SSB Crack News Researchers create novel polyphenol nanocarriers to enhance antibody delivery in cancer therapy  
103 7/11/2025 Newspaper/Web Chemical Daily iCONM-University of Tokyo. develops nucleic acid medicine nanomachine p.14
102 7/11/2025 Newspaper Nikkan Kogyo Shimbun Samco Foundation for Thin Film Technology Grants 10 p.21
101 7/11/2025 Newspaper Kyoto Shimbun Commemorative Lecture by Prof. Kataoka, Center Director of iConm, for the Thin Film Technology Grant, SAMCO Foundation p.11
100 7/10/2025 Web Yahoo! News Dai-ichi Life HD begins joint research with the University of Tokyo's Graduate School of Engineering.  
99 7/9/2025 Web NewSwitch Nanomachine to Deliver Antibody into Cancer Cells...Developed by Institute of Science Tokyo with Astringent Wine  
98 7/9/2025 Web Shin-Nihon Hoken Shimbun Dai-ichi Life Holdings and the University of Tokyo begin joint research  
97 7/8/2025 Web BioTecniques Novel nanocarrier could transform therapeutic antibody delivery  
96 7/8/2025 Web National Tribune Enhancing antibody therapies with polyphenol-conjugated nanocarriers for breast cancer  
95 7/8/2025 Web Mirage News Polyphenol Nanocarriers Boost Breast Cancer Antibodies  
94 7/8/2025 Web AzoNano Novel Polyphenol-Metal Nanocarrier for Antibody Delivery  
93 7/8/2025 Web/Newspaper Nikkan Kogyo Shimbun Institute of Science Tokyo, etc., Nanomachine using wine astringent to deliver antibodies into cancer cells p.23
92 7/7/2025 Web EurekAlert! Enhancing antibody therapies with polyphenol-conjugated nanocarriers for breast cancer  
91 7/7/2025 Web Nikkei Biotech Professor Itaka from Osaka University stated, "Achieving drug efficacy and safety that can only be realized with mRNA is crucial for the future of mRNA medicine."  
90 7/4/2025 Web Yahoo! News Polyphenols deliver antibodies inside cancer cells - Research team from Institute of Science Tokyo  
89 7/4/2025 Web Kagaku Shimbun "Delivering antisense nucleic acids to sentinel lymph nodes p.4
88 7/4/2025 Web CB news Polyphenols deliver antibodies into cancer cells - Research team from Institute of Science Tokyo  
87 7/4/2025 Web Nikkei Biotech Tokyo University and iCONM develop nanomedicine that accumulates antisense nucleic acids in lymph nodes to suppress cancer metastasis  
86 7/2/2025 Web Link-J Event Report Healthcare Engineering - Advanced Technology Development Aiming to Solve Issues in a Super-Aging Society’ 7th LINK-J/UC San Diego Life Sciences Symposium to be held on April 16.  
85 7/2/2025 Web STELLA News Nanomachines derived from polyphenols deliver antibodies into cancer cells - Institute of Science Tokyo develops new technology.  
84 7/2/2025 Web Iyaku Tsushin Sha On July 15, an online seminar on the theme 'Development of Novel Antibody DDS Formulations Utilizing DDS, Molecular Imaging, and Cell Biology' will be held by iCONM  
83 7/1/2025 Web/Magazine Sangyo Joho Kawasaki July Issue Kanmin-Kogaku Column⑳ Collaboration between hospitals and community nursing to support the people in therapeutic living. p.4
82 6/30/2025 Web Nihon-no-Kenkyu.com A new treatment method utilizing the 'astringency' components of wine to deliver antibodies into cancer cells has been developed. Nanomachines using polyphenols enhance the potential of antibody medicines  
81 6/30/2025 Web Iyaku Tsushin Sha Institute of Science Tokyo and iCONM develop polyphenol nanomachines derived from the astringent components of wine to deliver antibodies into cancer cells  
80 6/26/2025 Web / Newspaper Nikkan Kogyo Shimbun Developed next-generation mRNA drug technology p.28
79 6/26/2025 Web Iyaku-Tsushin-sha Development of Nanomachine to Deliver Nucleic Acid Drugs to Sentinel Lymph Nodes: iCONM and the University of Tokyo  
78 6/25/2025 Web e cancer Strengthening the guard at the checkpoint to prevent cancer metastasis  
77 6/25/2025 Web Nikkei Biotech iCONM: Stiffening the barrier defense and preventing cancer metastasis: Development of nanomachines that deliver nucleic acid drugs to sentinel lymph nodes.  
76 6/25/2025 Web Nippon-no Kenkyu Stiffening the barrier defense and preventing cancer metastasis: Development of nanomachines that deliver nucleic acid drugs to sentinel lymph nodes.  
75 6/24/2025 Web Nikkei Web iCONM and the University of Tokyo Develop Nanomachine to Deliver Nucleic Acid Drugs to Sentinel Lymph Nodes  
74 6/23/2025 Web Gate2 BioTech Precision nanomachines deliver gene therapy to lymph nodes, suppressing breast cancer spread  
73 6/23/2025 Web Phys & Org Precision nanomachines deliver gene therapy to lymph nodes, suppressing breast cancer spread  
72 6/23/2025 Web Life Technologies Innovative Polyplexes Boost Breast Cancer Treatment  
71 6/23/2025 Web EurekAlert! Strengthening the guard at the checkpoint to prevent cancer metastasis  
70 6/18/2025 Magazine Dream Navi August Issue My ON-OFF switching method / Yukihiro Kanda p.38
69 6/18/2025 YouTube Physique at chemie - College de France Self-Assembling Polymer Nanosystems: Towards Clinical Translation of Smart Drug Delivery  
68 6/18/2025 Newspaper Nikkei Shimbun Transformation Senzoku Gakuen: Learning and Career Development in the Suburbs  
67 6/17/2025 Web EurekAlert! To ensure that mRNA is delivered stably to the target tissue  
66 6/17/2025 Web Nikkei Web Senzoku Gakuen, off-campus career development, idea generation that outperforms AI, and mock UN  
65 6/15/2025 Web/Magazine Iyaku-Keizai 6/15 Issue Practitioner of medical-engineering collaboration Leading MRI researcher p.26
64 6/12/2025 Newspaper/Web Chemical Daily Pseudomonas aeruginosa mRNA Vaccine p.6
63 6/11/2025 Newspaper Nikkei Shimbun Shining People: Foreign human resources work hard to build bridges, making the most of their experience to coexist with local communities  
62 6/10/2025 Web Nikkei Biotech Development of next-generation mRNA medicine that automatically adjusts the amount of medicinal protein produced in response to cytosolic factors that are indicators of disease states.  
61 6/10/2025 Web Nikkei Web Kawasaki's experience is utilized to build bridges between the increasing number of foreign human resources and the local community.  
60 6/10/2025 Web Shimadzu User Interview To realize a “Smart Life Care Society” where people around the world can be healthy autonomously  
59 6/4/2025 Web Nan-Byo Network Korea's POSTECH and Kawasaki iCONM Partner on Next-Generation Cell/Gene Therapy Technology - International Collaboration Begins for Treatment of Intractable Diseases  
58 6/4/2025 Web NNA Asia Japanese and Korean Research Institutes Form Alliance to Develop Gene Therapy Drugs  
57 6/3/2025 Web KSM News Postech B-IRC and Japan's iCONM join forces to develop next-generation cell and gene therapeutic drug technology (Korea)  
56 6/3/2025 Web dkibo POSTECH B-IRC and Japan's iCONM sign MOU for joint research on next-generation cell and gene therapy technologies (Korea)  
55 6/3/2025 Web msn Japan Japan-Korea Collaboration to Bring New Life to Treatment of Intractable Diseases...Korea's POSTECH Signs MOU with Kawasaki iCONM  
54 6/3/2025 Web Iyaku-Tsushin-sha iCONM signed a Memorandum of Understanding with Korea Biotechnology Innovation Research Center for joint research and development  
53 6/3/2025 Web Infoseek Japan-Korea Collaboration to Bring New Life to Treatment of Intractable Diseases...Korea's POSTECH Signs MOU with Kawasaki iCONM  
52 6/3/2025 Web AFPBB News Japan-Korea Collaboration to Bring New Life to Treatment of Intractable Diseases...Korea's POSTECH Signs MOU with Kawasaki iCONM  
51 6/3/2025 Web Korea Wave Japan-Korea Collaboration to Bring New Life to Treatment of Intractable Diseases...Korea's POSTECH Signs MOU with Kawasaki iCONM  
50 6/2/2025 Web msn Korea POSTECH and Japan collaborate on next-generation cell and gene therapy technology (Korea)  
49 6/2/2025 Web Biz Herald POSTECH and Japan collaborate on next-generation cell and gene therapy technology (Korea)  
48 6/2/2025 Web daum news POSTECH and Japan collaborate on next-generation cell and gene therapy technology (Korea)  
47 6/2/2025 Web nate news POSTECH and Japan collaborate on next-generation cell and gene therapy technology (Korea)  
46 6/2/2025 Web zdnet POSTECH to embark on development of cell and gene therapeutics with Japan...MOU exchanged...Biomembrane technology and nano drug delivery system from both institutions combined (KOREA)  
45 6/2/2025 Web e-science POSTECH B-IRC signs MOU with Japan's iCONM on next-generation cell and gene therapy technology (Korea)  
44 6/2/2025 Web Nikkei Biotech iCONM signed a Memorandum of Understanding (MOU) for joint research and development with Korea's BioFuture Technology Innovation Research Center.  
43 6/2/2025 Web VERITAS POSTECH B-IRC and Japan's iCONM sign MOU for joint research on next-generation cell/gene therapy technology (Korea)  
42 6/2/2025 Web B-IRC / POSTECH POSTECH and Japan embark on joint research on next-generation cell and gene therapy technology (Korea)  
41 6/2/2025 Web Nikkei Biotech Transcription factor RUNX1 mRNA drug scheduled for Phase 1 in Australia  
40 6/1/2025 Web Iyaku-Keizai 6/1 Issue Practitioner of medical-engineering collaboration: Developed MRI contrast agent from artificial blood p.26
39 6/1/2025 Web/Magazine Sangyo-Joho Kawasaki
June Issue
Seminar Information: Development of Novel Antibody DDS Formulations Using DDS, Molecular Imaging, and Cell Biology p.3
38 6/1/2025 Web/Magazine Sangyo-Joho Kawasaki
June Issue
iCONM Column㉔ Gene therapy with nanomachines using wine ingredients p.3
37 6/1/2025 Web/Magazine Sangyo-Joho Kawasaki
June Issue
Nano-Medical Innovation Center Celebrates its 10th Anniversary p.1-2
36 5/30/2025 Newspaper Nikkei Shimbun NIKKEI Drug Discovery Ecosystem Summit Opening Special Feature: “Transforming the Development and Investment Environment for Breakthrough New Drugs from Japan”. p.28-29
35 5/23/2025 Newspaper Yomiuri Shimbun Future Researchers Experience Nanomedicine p.22
34 5/23/2025 Newspaper Kagaku Shimbun siRNA medicine for TNBC therapeutic purposes p.2
33 5/19/2025 Newspaper Sekiyu Kagaku Shimbun Toagosei develops a drug for treatment of intractable breast cancer / Joint research with iCONM, integrating siRNA and DDS  
32 5/16/2025 Web Iyaku-Tsushin-sha iCONM signed a joint research agreement with Toagosei on an innovative siRNA medicine for triple negative breast cancer treatment.  
31 5/15/2025 Web iptops.com iCONM and Toagosei sign collaboration agreement on innovative siRNA drugs for the treatment of triple-negative breast cancer.  
30 5/14/2025 Web Nikkei Web Toagosei enters drug discovery on a full scale, collaborating with Nano-Medical Center to develop drugs for intractable diseases.  
29 5/14/2025 Web/Newspaper Chemical Daily Toagosei-iCONM Collaborate in Nucleic Acid Drug Creation 7面
28 5/13/2025 Web Moneyworld iCONM and Toagosei sign collaboration agreement on innovative siRNA drugs for the treatment of triple-negative breast cancer.  
27 5/13/2025 Web IRSTREET iCONM and Toagosei sign collaboration agreement on innovative siRNA drugs for the treatment of triple-negative breast cancer.  
26 5/13/2025 Web Quick Money World iCONM and Toagosei sign collaboration agreement on innovative siRNA drugs for the treatment of triple-negative breast cancer.  
25 5/13/2025 Web Kabutan iCONM and Toagosei sign collaboration agreement on innovative siRNA drugs for the treatment of triple-negative breast cancer.  
24 5/13/2025 Web MINKABU iCONM and Toagosei sign collaboration agreement on innovative siRNA drugs for the treatment of triple-negative breast cancer.  
23 5/13/2025 Web Nikkei Web iCONM and Toagosei sign collaboration agreement on innovative siRNA drugs for the treatment of triple-negative breast cancer.  
22 5/9/2025 Newspaper Nikkei Shimbun Discovering Humanity: Kazunori Kataoka (3) Making "Fantastic Voyge" a Reality p.2
21 5/9/2025 Web Nikkei Web Human Discovery: Kazunori Kataoka, Director, iCONM Center Director (3)  
20 5/9/2025 Web Nikkei Web Making "Fantastic Voyage" a Reality / Kazunori Kataoka, iCONM Center Director  
19 5/8/2025 Newspaper Nikkei Shimbun Discovering Humanity: Kazunori Kataoka (2) Making "Fantastic Voyge" a Reality p.2
18 5/8/2025 Web Nikkei Web Human Discovery: Kazunori Kataoka, Director, iCONM Center Director (2)  
17 5/7/2025 Newspaper Nikkei Shimbun Discovering Humanity: Kazunori Kataoka (1) Making "Fantastic Voyge" a Reality p.2
16 5/7/2025 Web Nikkei Web Human Discovery: Kazunori Kataoka, Director, iCONM Center Director (1)  
15 5/2/2025 Newspaper Mainichi Shimbun Prejudice against “men's fields”? 10% of women in the Faculty of Engineering p.2
14 5/1/2025 Web/Magazin Sangyo-Joho Kawasaki
May Issue
Seminar Information: Engineering for Human Body Prof. Kohei Soga, Tokyo University of Science p.4
13 5/1/2025 Web/Magazin Sangyo-Joho Kawasaki
May Issue
Kanmin-Kogaku Column ⑲ Establishment of nursing IT promotion staffs and DXing of nursing operations initiatives at St. Marianne Medical University Hospital p.4
12 4/28/2025 Newspaper Nikkan Yakugyo The Health, Labor and Welfare Committee of the House of Councillors visited “PMDA” and “iCONM” to discuss the Pharmaceutical Affairs Law.  
11 4/24/2025 Web MSN ReseED Diversification of learning school inspection, PTA...Minister of Education, Culture, Sports, Science and Technology 4/22 press conference  
10 4/24/2025 Web Medifax The Health, Labor and Welfare Committee of the House of Councillors visited “PMDA” and “iCONM” to discuss the Pharmaceutical Affairs Law.  
9 4/23/2025 Web/Magazine iNewsletter 2025-Spring Issue Gene therapy with nanomachines loaded with wine ingredients p.3
8 4/22/2025 Newspaper Nihon Keizai Shimbun New mRNA Vaccine to be Approved for RS Virus, First Non-Corona Vaccine p.5
7 4/21/2025 Newspaper Nikkei Web MHLW subcommittee approves mRNA vaccine for RS virus, the first non-Corona mRNA vaccine.  
6 4/11/2025 Newspaper Kagaku Shimbun Muscular Dystrophy Treatment Success with mRNA Medicine p.4
5 4/4/2025 Web QLife Pro Muscular dystrophy, potential for innovative therapeutic development with mRNA medicine  
4 4/3/2025 Web RareS Successful treatment of a mouse model of Duchenne muscular dystrophy (DMD) using mRNA medicine.  
3 4/1/2025 Web/Magazine KNA News #116 Aiming for a safe and comfortable work environment p.4
2 4/1/2025 Web/Magazine Sangyo-Joho Kawasaki
April Issue
iCONM Column㉓ Innovation Center of NanoMedicine celebrates its 10th anniversary p.4
1 3/31/2025 Web Nikkei Biotech PGC-1α mRNA drug delivered by nanomicelle-type carrier and demonstrated the effectiveness in DMD mice